Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto M Martelli

Showing results (61-70 of 213) with videos related to

Pageof 22
Sort By:
Oncotarget|April 24, 2018
Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exerciseSimona Ultimo, Giorgio Zauli, Alberto M Martelli, et al.
Histology and Histopathology|August 9, 2015
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cellsFrancesca Salamanna, Stefania Pagani, Melania Maglio, et al.
Journal of Cellular Biochemistry|August 10, 2005
Nuclear inositol lipid metabolism: more than just second messenger generation?Alberto M Martelli, Matilde Yung Follo, Camilla Evangelisti, et al.
Advances in Enzyme Regulation|July 19, 2002
Inositides in the nucleus: regulation of nuclear PI-PLCbeta1Lucio Cocco, Alberto M Martelli, Marco Vitale, et al.
Journal of Cellular Biochemistry|July 12, 2002
Molecular characterization of protein kinase C-alpha binding to lamin AAlberto M Martelli, Roberta Bortul, Giovanna Tabellini, et al.
Advances in Enzyme Regulation|March 6, 2007
Nuclear inositide signaling: an appraisal of phospholipase C beta 1 behavior in myelodysplastic and leukemia cellsLucio Cocco, Matilde Y Follo, Irene Faenza, et al.
Advances in Biological Regulation|October 15, 2022
Effects of chloroquine and hydroxychloroquine on the sensitivity of pancreatic cancer cells to targeted therapiesJames A McCubrey, Stephen L Abrams, Matilde Y Follo, et al.
British Journal of Clinical Pharmacology|April 10, 2016
The therapeutic potential of mTOR inhibitors in breast cancerLinda S Steelman, Alberto M Martelli, Lucio Cocco, et al.
Oncotarget|September 17, 2013
The AKT inhibitor MK-2206 is cytotoxic in hepatocarcinoma cells displaying hyperphosphorylated AKT-1 and synergizes with conventional chemotherapyCarolina Simioni, Alberto M Martelli, Alice Cani, et al.
Oncotarget|October 10, 2014
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivationCarolina Simioni, Alice Cani, Alberto M Martelli, et al.
Pageof 22

Showing results (61-70 of 213) with videos related to

Sort By:
Pageof 22
Oncotarget|April 24, 2018
Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exerciseSimona Ultimo, Giorgio Zauli, Alberto M Martelli, et al.
Histology and Histopathology|August 9, 2015
Estrogen-deficient osteoporosis enhances the recruitment and activity of osteoclasts by breast cancer cellsFrancesca Salamanna, Stefania Pagani, Melania Maglio, et al.
Journal of Cellular Biochemistry|August 10, 2005
Nuclear inositol lipid metabolism: more than just second messenger generation?Alberto M Martelli, Matilde Yung Follo, Camilla Evangelisti, et al.
Advances in Enzyme Regulation|July 19, 2002
Inositides in the nucleus: regulation of nuclear PI-PLCbeta1Lucio Cocco, Alberto M Martelli, Marco Vitale, et al.
Journal of Cellular Biochemistry|July 12, 2002
Molecular characterization of protein kinase C-alpha binding to lamin AAlberto M Martelli, Roberta Bortul, Giovanna Tabellini, et al.
Advances in Enzyme Regulation|March 6, 2007
Nuclear inositide signaling: an appraisal of phospholipase C beta 1 behavior in myelodysplastic and leukemia cellsLucio Cocco, Matilde Y Follo, Irene Faenza, et al.
Advances in Biological Regulation|October 15, 2022
Effects of chloroquine and hydroxychloroquine on the sensitivity of pancreatic cancer cells to targeted therapiesJames A McCubrey, Stephen L Abrams, Matilde Y Follo, et al.
British Journal of Clinical Pharmacology|April 10, 2016
The therapeutic potential of mTOR inhibitors in breast cancerLinda S Steelman, Alberto M Martelli, Lucio Cocco, et al.
Oncotarget|September 17, 2013
The AKT inhibitor MK-2206 is cytotoxic in hepatocarcinoma cells displaying hyperphosphorylated AKT-1 and synergizes with conventional chemotherapyCarolina Simioni, Alberto M Martelli, Alice Cani, et al.
Oncotarget|October 10, 2014
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivationCarolina Simioni, Alice Cani, Alberto M Martelli, et al.
Pageof 22